Natural History Study of SCID Disorders
This study is for children diagnosed with 'Severe Combined Immunodeficiency' (SCID), a serious condition where the body's immune system doesn't work properly. Researchers are observing how children with different types of SCID respond to existing treatments like bone marrow transplants, enzyme therapy, or gene therapy. They want to learn more about which treatments lead to the best long-term health and how factors like timing and donor choice affect outcomes. This is not a study testing new medicines; it's about carefully watching and collecting information from usual care to improve future treatments for children with SCID.
At a glance
What is this study about?
Imagine your body's immune system as a superhero team protecting you from germs and illnesses. For children with Severe Combined Immunodeficiency, or SCID, this superhero team is missing or very weak, leaving them vulnerable to serious infections. This can be a life-threatening condition.
This study is designed to help doctors understand SCID better and find the best ways to treat it. They are carefully observing children who are already receiving treatments like blood and marrow transplants, enzyme therapy, or gene therapy. It's like taking notes on many different children's journeys to see what helps them get better and stay healthy for a long time. The study will gather details about the child, their specific type of SCID, and the treatment they receive, from before treatment to many years after.
The main goals are to discover which treatment approaches work best in today's medicine, what factors contribute to the healthiest long-term outcomes (like finding the right donor or the best time for treatment), and how early diagnosis through newborn screening impacts a child’s health after treatment. They also want to understand how a child's immune system recovers, how their quality of life is, and if they grow and develop normally. This knowledge will help doctors give even better care to children with SCID in the future.
This is the largest study of its kind, and it's simply observing what happens with current treatments – no experimental drugs or procedures are involved. By bringing together information from many children, researchers hope to uncover important patterns and insights that will ultimately improve the lives of all children living with SCID.
Key takeaways
- The study aims to understand SCID and its treatments better.
- It observes outcomes of existing treatments, not new ones.
- Data collected will help improve future care for children with SCID.
- No extra tests or medications beyond standard care.
- Participation involves sharing medical information over time.
- You can withdraw your child at any point without affecting their care.
Who may be eligible?
This study is looking for children diagnosed with Severe Combined Immunodeficiency (SCID) or similar conditions like Leaky SCID, Omenn Syndrome, or Reticular Dysgenesis, who are planning to have treatments such as a bone marrow transplant, enzyme therapy, or gene therapy.
To join, a child must have specific blood test results that show very low numbers of certain immune cells (T cells) or very poor T cell function, which are hallmarks of SCID. For some types of SCID, researchers will also look for particular genetic changes, but the main focus is on the immune cell counts and their ability to fight off disease.
Essentially, if your child has been diagnosed with a type of SCID where their immune system is severely compromised and they are about to receive, or have recently received, one of the standard treatments for SCID, they might be able to participate. The study is open to children of all ages and genders.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- My child has been diagnosed with a type of SCID (e.g., Leaky SCID, Omenn Syndrome).
- My child's blood tests show very low numbers or function of certain immune cells (T cells).
- My child is planning to receive, or has recently received, a bone marrow transplant, enzyme therapy, or gene therapy for SCID.
- My child is of any age and any gender.
What does participation involve?
If your child joins this study, they will be observed closely over time. This means doctors will collect information from their regular medical appointments and treatments related to their SCID. They will keep track of how your child's immune system responds after treatment, how they are growing and developing, and their general quality of life.
The study doesn't involve any extra tests or medications that your child wouldn't already be getting as part of their standard medical care. Instead, it uses information from those routine check-ups and procedures. There are no experimental treatments being given within this study. It's about collecting existing data on your child's health journey according to a set schedule, both before and after their treatment for SCID, for a period determined by the study protocol. The overall duration of your child's participation will depend on the follow-up schedule required to gather all the necessary information.
Potential risks and benefits
Locations (44)
- University of Alabama at BirminghamVerified postcodeBirmingham, United States
- Phoenix Children's HospitalVerified postcodePhoenix, United States
- Children's Hospital Los AngelesVerified postcodeLos Angeles, United States
- University of California, Los AngelesVerified postcodeLos Angeles, United States
- Lucile Salter Packard Children's Hospital at StanfordVerified postcodePalo Alto, United States
- University of California San Francisco Children's HospitalVerified postcodeSan Francisco, United States
- Children's Hospital DenverVerified postcodeDenver, United States
- Alfred I. duPont Hospital for Children/NemoursVerified postcodeWilmington, United States
- Children's National Medical CenterVerified postcodeWashington D.C., United States
- Johns Hopkins All Children's HospitalVerified postcodeSt. Petersburg, United States
- Children's Healthcare of Atlanta/Emory University School of MedicineVerified postcodeAtlanta, United States
- Ann & Robert H. Lurie Children's Hospital of ChicagoVerified postcodeChicago, United States
Common questions
What is SCID?
SCID stands for Severe Combined Immunodeficiency. It's a very serious inherited condition where a child's immune system cannot fight off infections, making them very vulnerable to illness.
Is this study testing a new medicine?
No, this study is not testing new medicines or treatments. It's observing how children respond to existing, approved SCID treatments like bone marrow transplants or gene therapy. Researchers are collecting information, not trying out new drugs.
Will my child receive extra medical care if we join?
No, your child will continue to receive the same medical care they would normally get for their SCID. This study collects information from those usual visits and treatments; it doesn't add new tests or procedures.
Why is this study important?
By looking at how many children with SCID respond to current treatments, doctors hope to learn which methods work best and how to improve future care, leading to healthier lives for children with SCID.
Can I take my child out of the study at any time?
Yes, you are completely free to withdraw your child from the study at any time, for any reason, and it will not affect the medical care they receive.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.